Table: Stella Pharma - 6-MTH parent results

Stella Pharma

08/11/2021 06:20

Nov 8 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2021        Sep 30, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            69 mln                                123 mln    
                                                       (-40.3 pct)  
  Operating     loss 337 mln                          loss 775 mln  
  Recurring     loss 406 mln                          loss 827 mln  
  Net           loss 408 mln                          loss 831 mln  
  EPS          loss 14.85 yen                        loss 29.60 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T